Israel - inglês - Ministry of Health

megapharm ltd - bleomycin sulfate - powder for solution for injection - bleomycin sulfate 15000 iu/vial - bleomycin - bleomycin - bleomycin is useful in the management of the following neoplasms: squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. well differentiated tumors usually respond better than anaplastic ones.hodgkin's disease and other malignant lymphomas, including mycosis fungoides. testicular carcinoma (seminoma and no seminoma) .malignant effusions of serous cavities (intrapleural and intraperitoneal).secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. local treatment of refractory warts. bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

Estados Unidos - inglês - NLM (National Library of Medicine)

teva parenteral medicines, inc. - bleomycin sulfate (unii: 7dp3ntv15t) (bleomycin - unii:40s1vhn69b) - bleomycin 15 [usp'u] - bleomycin for injection should be considered a palliative treatment. it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. the response to bleomycin is poorer in patients with previously irradiated head and neck cancer. hodgkin's disease, non-hodgkin's lymphoma. embryonal cell, choriocarcinoma, and teratocarcinoma. bleomycin for injection has also been shown to be useful in the management of: bleomycin for injection is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions. bleomycin is contraindicated in patients who have demonstrated a hypersensitive or an idiosyncratic reaction to it.

Estados Unidos - inglês - NLM (National Library of Medicine)

fresenius kabi usa, llc - bleomycin sulfate (unii: 7dp3ntv15t) (bleomycin - unii:40s1vhn69b) - bleomycin 30 [usp'u] - bleomycin for injection, usp should be considered a palliative treatment.  it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: squamous cell carcinoma: head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva.  the response to bleomycin for injection is poorer in patients with previously irradiated head and neck cancer. lymphomas: hodgkin’s disease, non-hodgkin’s lymphoma. testicular carcinoma: embryonal cell, choriocarcinoma, and teratocarcinoma. bleomycin for injection, usp has also been shown to be useful in the management of: malignant pleural effusion: bleomycin for injection is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions. bleomycin for injection is contraindicated in patients who ha

Estados Unidos - inglês - NLM (National Library of Medicine)

hospira, inc. - bleomycin sulfate (unii: 7dp3ntv15t) (bleomycin - unii:40s1vhn69b) - bleomycin 30 [usp'u] - bleomycin for injection should be considered a palliative treatment. it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: squamous cell carcinoma head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. the response to bleomycin is poorer in patients with previously irradiated head and neck cancer. lymphomas hodgkin's disease, non-hodgkin's lymphoma. testicular carcinoma embryonal cell, choriocarcinoma, and teratocarcinoma. bleomycin has also been shown to be useful in the management of: malignant pleural effusion bleomycin is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions. bleomycin for injection is contraindicated in patients who have demonstrated a hypersensitive or an idiosyncratic reaction to it.

Estados Unidos - inglês - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - bleomycin sulfate (unii: 7dp3ntv15t) (bleomycin - unii:40s1vhn69b) - bleomycin 15 [usp'u] - bleomycin for injection, usp should be considered a palliative treatment. it has been shown to be useful in the management of the head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. the response to bleomycin is poorer in patients with previously irradiated head and neck cancer. hodgkin's disease, non-hodgkin's lymphoma. embryonal cell, choriocarcinoma, and teratocarcinoma. bleomycin for injection, usp has also been shown to be useful in the management of: bleomycin is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions. bleomycin is contraindicated in patients who have demonstrated a hypersensitive or an idiosyncratic reaction to it.

França - francês - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

accord healthcare france sas - bléomycine 15 000 ui sous forme de : sulfate de bléomycine - poudre - 15 000 ui - pour un flacon > bléomycine 15 000 ui sous forme de : sulfate de bléomycine - antibiotiques cytotoxiques et substances apparentées - classe pharmacothérapeutique - code atc : antibiotiques cytotoxiques et substances apparentées, code atc : l01dc01.ce médicament contient comme substance active du sulfate de bléomycine. la bléomycine appartient à un groupe de médicaments appelés les médicaments cytostatiques. ce sont des médicaments anticancéreux parfois appelés chimiothérapie. ils attaquent les cellules cancéreuses et les empêchent de se diviser.bleomycine accord est utilisé pour traiter : certains types de cancer (carcinomes épidermoïdes) dans la tête et le cou, le col de l’utérus et les organes génitaux externes ; certains types de cancer des ganglions lymphatiques (p. ex. maladie de hodgkin et lymphome non hodgkinien de malignité intermédiaire et élevée) ; cancer testiculaire ; accumulation de liquide dans les poumons (à la suite d’un cancer).la bléomycine peut soit être utilisée seule ou en association avec d’autres médicaments anticancéreux, et/ou en association avec la radiothérapie.

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medac - bleomicin - prašek za raztopino za injiciranje - bleomicin 15000 i.e. / 1 viala - bleomicin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmachemie b.v. - bleomicin - prašek za raztopino za injiciranje - bleomicin 15000 i.e. / 1 viala - bleomicin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmachemie b.v. - bleomicin - prašek za raztopino za injiciranje - bleomicin 15000 i.e. / 1 viala - bleomicin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medac - bleomicin - prašek za raztopino za injiciranje - bleomicin 15000 i.e. / 1 viala - bleomicin